AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...
A new development in wireless sensing technology that can reliably screen for five common pulmonary diseases could lead to ...
Mount Sinai analysis looks at the effectiveness of electrocardiograms analyzed via deep learning as a tool for early COPD detection ...
Freenome today announced an initiative to advance its blood-based early cancer screening program by leveraging NVIDIA deep learning technology and expertise to improve the recognition of ...
Labcorp is a global leader of innovative and comprehensive laboratory services. The company's Venture Fund invests in and supports early stage, private companies that are focused on improving health ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
Biological age tests measure how fast your body is aging compared to your actual age. These tests rely on biomarkers tied to ...
Explore how nanotechnology acts as the 'Convergence Engine' for AI materials discovery, CRISPR gene therapy delivery, and industrial quantum computing in 2025.
Converge Bio, the AI platform for accelerated drug discovery and development, announced today $25 million in Series A funding ...
Automated diagnosis of chronic obstructive pulmonary disease using deep learning applied to electrocardiogramsJournal: eBioMedicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback